Use of gelatin-acacia coacervate containing benzocaine in topical formulations

Andreas M. Ichwan, Manous Karimi, Alekha K. Dash

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The in vitro release of a drug from topical formulations depends on the concentration of the drug in the formulation, the solubility of the drug in the base, the diffusion coefficient of the drug in the vehicle, and the partition coefficient of the drug between the vehicle, and the release medium. Incorporation of both complexing agents and cosolvents into such formulations has been used to enhance the in vitro release of a drug from topical formulations. In this investigation, a novel approach to enhance the in vitro release of benzocaine from different ointment formulations has been introduced. In this study, benzocaine was microencapsulated using gelatin- acacia complex coacervation technique. Various weight fractions of the coacervate, 5, 10, and 20% (w/w), were incorporated into both oleaginous and absorption bases. The in vitro release characteristics of benzocaine from the resulting ointments were studied using a modified USP Dissolution Apparatus 2. A plot of the cumulative amount of drug released (7-8%) per unit surface area versus (time) 1/2 was linear. Microscopic studies of the formulations revealed that the coacervates maintained their integrity in the formulation during the preparation and storage of the dosage form. Differential scanning calorimetric (DSC) studies indicated that the drug existed in the crystalline state in all formulations including those at a low drug load (0.5% w/w). DSC was also used to determine the solubility of the drug in the formulation. The rate and extent of drug release was higher in the absorption base as compared to the oleaginous base.

Original languageEnglish
Pages (from-to)763-766
Number of pages4
JournalJournal of Pharmaceutical Sciences
Volume88
Issue number8
DOIs
StatePublished - Aug 1999

Fingerprint

Benzocaine
Acacia
Gelatin
Drug Compounding
Pharmaceutical Preparations
Ointments
Solubility
Dosage Forms
Scanning
Weights and Measures
In Vitro Techniques
Dissolution

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science
  • Pharmacology

Cite this

Use of gelatin-acacia coacervate containing benzocaine in topical formulations. / Ichwan, Andreas M.; Karimi, Manous; Dash, Alekha K.

In: Journal of Pharmaceutical Sciences, Vol. 88, No. 8, 08.1999, p. 763-766.

Research output: Contribution to journalArticle

@article{c655ca715d094ccfad8c08fd6581eb0a,
title = "Use of gelatin-acacia coacervate containing benzocaine in topical formulations",
abstract = "The in vitro release of a drug from topical formulations depends on the concentration of the drug in the formulation, the solubility of the drug in the base, the diffusion coefficient of the drug in the vehicle, and the partition coefficient of the drug between the vehicle, and the release medium. Incorporation of both complexing agents and cosolvents into such formulations has been used to enhance the in vitro release of a drug from topical formulations. In this investigation, a novel approach to enhance the in vitro release of benzocaine from different ointment formulations has been introduced. In this study, benzocaine was microencapsulated using gelatin- acacia complex coacervation technique. Various weight fractions of the coacervate, 5, 10, and 20{\%} (w/w), were incorporated into both oleaginous and absorption bases. The in vitro release characteristics of benzocaine from the resulting ointments were studied using a modified USP Dissolution Apparatus 2. A plot of the cumulative amount of drug released (7-8{\%}) per unit surface area versus (time) 1/2 was linear. Microscopic studies of the formulations revealed that the coacervates maintained their integrity in the formulation during the preparation and storage of the dosage form. Differential scanning calorimetric (DSC) studies indicated that the drug existed in the crystalline state in all formulations including those at a low drug load (0.5{\%} w/w). DSC was also used to determine the solubility of the drug in the formulation. The rate and extent of drug release was higher in the absorption base as compared to the oleaginous base.",
author = "Ichwan, {Andreas M.} and Manous Karimi and Dash, {Alekha K.}",
year = "1999",
month = "8",
doi = "10.1021/js9805017",
language = "English",
volume = "88",
pages = "763--766",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Use of gelatin-acacia coacervate containing benzocaine in topical formulations

AU - Ichwan, Andreas M.

AU - Karimi, Manous

AU - Dash, Alekha K.

PY - 1999/8

Y1 - 1999/8

N2 - The in vitro release of a drug from topical formulations depends on the concentration of the drug in the formulation, the solubility of the drug in the base, the diffusion coefficient of the drug in the vehicle, and the partition coefficient of the drug between the vehicle, and the release medium. Incorporation of both complexing agents and cosolvents into such formulations has been used to enhance the in vitro release of a drug from topical formulations. In this investigation, a novel approach to enhance the in vitro release of benzocaine from different ointment formulations has been introduced. In this study, benzocaine was microencapsulated using gelatin- acacia complex coacervation technique. Various weight fractions of the coacervate, 5, 10, and 20% (w/w), were incorporated into both oleaginous and absorption bases. The in vitro release characteristics of benzocaine from the resulting ointments were studied using a modified USP Dissolution Apparatus 2. A plot of the cumulative amount of drug released (7-8%) per unit surface area versus (time) 1/2 was linear. Microscopic studies of the formulations revealed that the coacervates maintained their integrity in the formulation during the preparation and storage of the dosage form. Differential scanning calorimetric (DSC) studies indicated that the drug existed in the crystalline state in all formulations including those at a low drug load (0.5% w/w). DSC was also used to determine the solubility of the drug in the formulation. The rate and extent of drug release was higher in the absorption base as compared to the oleaginous base.

AB - The in vitro release of a drug from topical formulations depends on the concentration of the drug in the formulation, the solubility of the drug in the base, the diffusion coefficient of the drug in the vehicle, and the partition coefficient of the drug between the vehicle, and the release medium. Incorporation of both complexing agents and cosolvents into such formulations has been used to enhance the in vitro release of a drug from topical formulations. In this investigation, a novel approach to enhance the in vitro release of benzocaine from different ointment formulations has been introduced. In this study, benzocaine was microencapsulated using gelatin- acacia complex coacervation technique. Various weight fractions of the coacervate, 5, 10, and 20% (w/w), were incorporated into both oleaginous and absorption bases. The in vitro release characteristics of benzocaine from the resulting ointments were studied using a modified USP Dissolution Apparatus 2. A plot of the cumulative amount of drug released (7-8%) per unit surface area versus (time) 1/2 was linear. Microscopic studies of the formulations revealed that the coacervates maintained their integrity in the formulation during the preparation and storage of the dosage form. Differential scanning calorimetric (DSC) studies indicated that the drug existed in the crystalline state in all formulations including those at a low drug load (0.5% w/w). DSC was also used to determine the solubility of the drug in the formulation. The rate and extent of drug release was higher in the absorption base as compared to the oleaginous base.

UR - http://www.scopus.com/inward/record.url?scp=0032803333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032803333&partnerID=8YFLogxK

U2 - 10.1021/js9805017

DO - 10.1021/js9805017

M3 - Article

VL - 88

SP - 763

EP - 766

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 8

ER -